NCT01100723
- Conditions
- Chronic Disease, Chronic Kidney Disease, Disease Attributes, +16 more
- Locations
-
- Lynchburg Nephrology Associates, P.L.L.C. Lynchburg, Virginia, United States
Clinical trial condition
Hyperparathyroidism, Secondary
Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.
148 public trials
8 recruiting studies
Hyperparathyroidism, Secondary trial results
NCT01191762
- Conditions
- Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
- Locations
-
- Stratton Veterans Affairs Medical Center Albany, New York, United States
NCT02282813
- Conditions
- Avitaminosis, Chronic Disease, Chronic Kidney Disease, +21 more
- Locations
-
Not specified
NCT01219855
- Conditions
- Chronic Disease, Chronic Kidney Disease, Disease Attributes, +17 more
- Locations
-
- OPKO Health, Inc Bannockburn, Illinois, United States
NCT00828347
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- Kumamoto University Hospital Kumamoto, Japan
NCT00528788
- Conditions
- Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
- Locations
-
- Duke University Medical Center Dialysis Unit Durham, North Carolina, United States
NCT00397475
- Conditions
- Chronic Disease, Disease Attributes, Endocrine System Diseases, +13 more
- Locations
-
- University Hospital of Saarland, Dpt. of Internal Medicine IV, Div. of Nephrology and Hypertension Homburg, Saarland, Germany
NCT00123461
- Conditions
- Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +16 more
- Locations
-
- AKDHC Medical Research Services Phoenix, Arizona, United States
- UCLA Diabetes Reseach Center Alhambra, California, United States
- Apex Research of Riverside Riverside, California, United States
- George Washington University Hospital Washington D.C., District of Columbia, United States
NCT00454350
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- Minneapolis, Minnesota, United States
Completed
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
NCT00463021
- Conditions
- Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
- Locations
-
- Downey, California, United States
- Paramount, California, United States
- Hudson, Florida, United States
- Augusta, Georgia, United States